According to GlobalData’s medical device pipeline database, 12 Implanted Electrical Urinary Continence Device devices are in various stages of development globally. GlobalData’s report Implanted electrical urinary continence device provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, six are in active development, while the remaining six are in an inactive stage of development. There are four products in the early stages of development, and the remaining two are in the late stages of development.
Nephrology and urology devices are used to diagnose, treat, and manage diseases of the kidneys, urinary tract, and male reproductive system. Implanted electrical urinary continence device (IUC) is surgically placed in the body to help control urinary incontinence. IUCs work by sending electrical impulses to the pelvic floor muscles, which helps to strengthen them and improve their ability to control urination. Implanted electrical urinary continence device are used to treat stress urinary incontinence (SUI), which is a type of incontinence that occurs when there is increased pressure in the abdomen, such as during coughing, sneezing, or laughing. IUCs can also be used to treat Urge Urinary Incontinence (UUI), which is a type of incontinence that occurs when the bladder suddenly contracts and leaks urine.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Implanted Electrical Urinary Continence Device pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Implanted Electrical Urinary Continence Device devices. Overall, most of these Implanted Electrical Urinary Continence Device pipeline devices are being developed by private entities.
Key players involved in the active development of Implanted Electrical Urinary Continence Device include Implantica CE & Production, Medi-Globe, MyoPowers Medical Technologies France, Polytechnique Montreal, Precision Medical Devices, UroMems, Washington University in St Louis, Amber Therapeutics, DUALIS MedTech and EndoStim.
For a complete picture of the developmental pipeline for Implanted Electrical Urinary Continence Device devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
